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Pneumonia of unknown cause was detected on 30 December 2019 in China. It was catego-
rized as an outbreak and named as COVID-19 by theWorld Health Organization. The pan-
demic affects all people, but patient groups such as hemodialysis (HD) patients have been
particularly affected. We do not know if refugees suffered more during the outbreak. In this
study, we compared depressive symptom frequency between Syrian refugee HD patients
and Turkish ones.
Methods
The study had a single-center, cross-sectional design. Demographic and clinical data were
collected retrospectively from patients’ files containing details about past medical history,
demographic variables and laboratory values. Validated Turkish and Arabic forms of Beck
Depression Inventory (BDI) were used to assess depressive symptoms. BDI scores were
compared according to nationality, demographic features and clinical data. A BDI score
more than 14 was accepted as suspicion of depression.
Results
119 patients were enrolled in the study. After the exclusion of 22 patients, 75 Turkish and 22
Syrian patients were included for further analysis. The median BDI (interquartile range)
score for Turkish and Syrian patients were 12 (7–23) and 19.5 (12.7–25.2), respectively (p =
0.03). Suspicion of depression was present at 42.7% of Turkish, and 72.7% of Syrian HD
patients (p = 0.013). Regarding all patients, phosphorus level, Kt/V, and nationality were
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significantly different between patients with and without suspicion of depression (p = 0.023,
0.039, 0.013, respectively).
Conclusion
Syrian patients had higher BDI scores and more depressive symptoms than Turkish
patients. Additional national measures for better integration and more mental support to Syr-
ian HD patients are needed.
Introduction
Pneumonia of unknown cause was detected on 30 December 2019 in China. It was categorized
as an outbreak and named as COVID-19 by the World Health Organization [1]. The first
COVID-19 case was reported on 10 March 2020 in Turkey [2]. People older than 65 years old
began their lockdown on 21 March 2020 and people younger than 20 years old started to lock-
down on 03 April 2020. Total lockdown has been done a few times lasting for three or four
days, especially at weekends.
Renal replacement modalities have been affected in different ways during the pandemic.
Patients with kidney transplantation, performing home hemodialysis (HD) and peritoneal
dialysis have been advised to isolate themselves at homes. However, center HD patients con-
tinued to attend dialysis centers.
Depression is a frequent co-morbidity at HD patients. It can be screened by a few types of
self-questionnaires validated in this population such as Beck depression inventory (BDI) [3].
The frequency of depressive symptoms during pandemic on chronic HD patients is not
known.
The Syrian civil war started on 11 March 2011. Turkey currently hosts 3.6 million registered
Syrian refugees [4]. There are many Syrian center HD patients both in Turkey and in our unit.
The number of Syrian refugees under HD therapy was 345 in 2019 [5]. We do not know if
there is a difference in depressive symptom frequency between Syrian refugee HD patients and
Turkish ones or not. This study aims to compare BDI scores of Turkish and Syrian mainte-
nance HD patients during the COVID-19 pandemic.
Methods
This cross-sectional study (Clinicaltrials.gov: NCT04444557) was approved by the local ethics
committee of Sisli Hamidiye Etfal Education and Research Hospital on 12 May 2020
(Ref. number 1514). All data were fully anonymized before access. Participants signed written
consent forms both to participate in the study and to have data from their medical records
used in research.
All HD patients in the same center were invited to participate in the study. Exclusion crite-
ria were as follows: patients younger than 18 years old, patients undergoing home-HD, history
of HD less than three months, inability to complete the questionnaire, nationalities other than
Turkish and Syrian, not volunteering to fill the form, history of hospitalization due to any rea-
son during pandemic time starting from 10 March 2020, and history of COVID-19 before
questionnaire. BDI forms were filled between 17 April 2020 and 12 May 2020. Past medical
records were accessed at the same day patients completed the BDI questionnaire.
Demographic data were collected retrospectively from patients’ files. These files contain the
demographic details of patients filled at admission to our dialysis center and patients’ past and
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current laboratory values. Age, sex, nationality, marital status, education level, height, weight,
etiology of kidney disease, the date for initiation of center HD, last hemoglobin, albumin,
phosphorus, parathyroid hormone, Kt/v, creatinine levels and, Charlson comorbidity index
were noted. Marital status was grouped as married and not married including single, divorced,
and widow.
BDI consists of 21 questions and every question has four choices ranging from 0 to 3 in
which 0 represents the absence of a problem, and 3 represents an extreme problem. Therefore,
the total BDI score can be between 0 and 63 points. BDI score of more than 14 was accepted as
suspicion of depression in patients with end-stage renal disease (ESRD) [6–8]. The frequencies
of depressive symptoms were compared between nationalities. The validated Turkish and Ara-
bic forms of BDI version-I were filled by patients themselves [9–11]. If help was required to
complete the questionnaire, a native Arabic physician working at our hemodialysis center (SS)
and the official Arabic translator of our institution (SA) helped Syrian patients.
BDI score was compared according to age group (<65 years or�65 years), sex, education
level, marital status, body mass index (<25 kg/m2, 25–30 kg/m2,>30 kg/m2), presence of dia-
betes mellitus, presence of hypertension, HD vintage (below or above median), hemoglobin
level (<10 g/dl, 10–12 g/dl,>12 g/dl), phosphorus level (<3.5 mg/dl, 3.5–5.5 mg/dl,>5.5 mg/
dl), albumin level (<3.5 gr/dl or�3.5 gr/dl), parathyroid hormone level (below or above
median), Kt/v (<1.4 or�1.4), and nationality. BDI score was also divided into cognitive-affec-
tive and somatic-performance subscales [12]. These were compared to nationality as well.
Statistical analysis
Statistical analyses were performed with the Scientific Package for Social Science (version 21.0;
SPSS Inc., Chicago, IL, USA). Continuous variables were given as mean ± standard deviation
if they were distributed normally or as median (interquartile range) if they were distributed
abnormally. Qualitative variables were given as a percentage. A comparison of normally dis-
tributed data was performed by independent samples t-test. Abnormally distributed data was
compared with the Mann-Whitney U test. Categorical variables were compared by the Chi-
Square test. Differences were considered statistically significant for p values less than 0.05.
Results
One hundred and nineteen patients were enrolled to the study. After the exclusion of 22
patients for a range of reasons, 75 Turkish and 22 Syrian patients were included for further
analysis (Fig 1). The mean age of patients was 51.6 ± 15.5 years. The most common cause of
ESRD was hypertension (32%). Median HD vintage was 3.7 (1.8–7.4) years (Table 1).
The mean age for Turkish patients was 52.1 ± 16.1 years and 49.9 ± 13.2 years for Syrian
patients (p = 0.568) (Table 1). Female patients were 52.0% of the Turkish cohort and 18.2% of
the Syrian cohort (p = 0.005). The education level was similar between the two nationalities
(p = 0.06). Marriage rate was 49.3% in Turkish and 81.8% in Syrian patients (p = 0.007).
The median BDI score for Turkish patients was 12 (7–23). It was 19.5 (12.7–25.2) for Syrian
patients (p = 0.03) (Fig 2). The median somatic-performance subscale scores for Turkish and
Syrian patients were 2 (1–5) and 3.5 (2–6.2), respectively (p = 0.02). Affective-cognitive sub-
scale median score for Turkish patients was 9 (6–18) whereas it was 14 (10–18) for Syrian
patients (p = 0.05).
Depressive symptoms were present in 49.5% of the total cohort. Patients with and without
depressive symptoms were compared on multiple variables (Table 2). Phosphorus level and
Kt/V were found different between two groups (p = 0.023, 0.039, respectively). Depressive
symptoms were present at 42.7% of Turkish, and 72.7% of Syrian HD patients (p = 0.013).
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Discussion
This study investigated BDI scores between Turkish and Syrian HD patients during the
COVID-19 pandemic. Syrian patients had higher BDI scores than Turkish patients.
After Turkey has started to accept refugees from Syria, free healthcare facilities including
hemodialysis and kidney transplantation were established [13]. For HD, Syrian and Turkish
patients have equal conditions including HD schedules (three times a week, four hours), and
transport facilities. Drugs are supplied free of charge to Syrian patients, like Turkish ones. The
groups were similar in many respects, with laboratory features hemoglobin, phosphorus, albu-
min, parathyroid hormone, Kt/V in both groups not differing significantly between the Syrian
and Turkish patients. In our cohort, most of the Syrian patients (81.8%) were male, although
54.0% of all Syrian refugees [14] and 51.6% of Syrian hemodialysis patients [5] in Turkey were
male. There could be a male predominance by chance in our dialysis center.
Screening frequency of depressive symptoms by the BDI score without a clinical interview
is an established strategy in ESRD patients [3, 7, 8]. BDI-I questionnaire was used in this study
because of some advantages. It was a practical, easy, reliable and valid self-report system that
has been used since 1961 [11, 15]. It could be completed by patients themselves which would
minimize close and long contacts with patients during the pandemic and prevent potential
COVID-19 transmission. Moreover, to the best of our knowledge, it is the only self-report
screening measure that has been validated in both Turkish and Arabic languages. Besides these
advantages, BDI-I form has some limitations. It has been focused more on cognitive and
Fig 1. Details of the patient cohort. After enrollment of all center hemodialysis patients (n = 119), 22 patients were
excluded due to following reasons: unwilling to participate (n = 4), younger than 18 years old (n = 3), inability to
cooperate (n = 6), COVID-19 history (n = 5), hemodialysis history less than 3 months (n = 2), other nationalities
(n = 2). Seventy-five Turkish, 22 Syrian patients’ data were analyzed further.
https://doi.org/10.1371/journal.pone.0244347.g001
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affective symptoms than somatic functions. Furthermore, it could be biased by organic symp-
toms. It was updated as BDI-II form at 1996 in response to American Psychiatric Association’s
publication of DSM-IV criteria for major depressive disorder [16]. Despite this updated ver-
sion, BDI-I is still widely used in different patient populations [17].
Patients with and without depressive symptoms had similar demographic and laboratory
features except for phosphorus level, Kt/V, and nationality. Some similar studies found no
association between depressive symptoms and phosphorus level or Kt/V although the number
of participants was less than our cohort and the definition of suspicion of depression was dif-
ferent from each other in all studies [18–21]. The difference between our study and previous
studies may be due to these reasons. Furthermore, there are many additional probable reasons
including adherence to diet and prescribed drugs, quality of hemodialysis, etc. These factors,
unfortunately, were not in the scope of the trial design.
Table 1. Demographic characteristics, laboratory values of all patients, Turkish, and Syrian subgroups.
Parameter All patients (n = 97) Turkish (n = 75) Syrian (n = 22) p
Age, years, mean ± SD 51.6±15.5 52.1±16.1 49.9±13.2 0.568
Female patients (%) 44.3 52 18.2 0.005
Education level (%) 0.060
Illiterate 6.0 4.8 9.5
Literate 15.7 16.1 14.3
Primary school 49.4 53.2 38.1
Secondary school 13.3 14.5 9.5
High school 12 11.3 14.3
University 3.6 - 14.3
Marital status 0.007
Married (%) 56.7 49.3 81.8
BMI, kg/m2, median (IR) 21.8 (19.2–25.0) 21.9 (19.3–25.3) 21.1 (19.1–24.2) 0.435
ESRD etiology (%) 0.905
Diabetes 18.6 20 13.6
Hypertension 32 32 31.8
Glomerulonephritis 7.2 6.7 9.1
Polycystic kidney disease 7.2 8 4.5
Unknown 14.4 12 22.7
Miscellaneous 20.6 21.3 18.2
Diabetes mellitus (%) 21.6 24 13.6 0.299
Hypertension (%) 47.4 48 45.5 0.833
Hemodialysis vintage, years, median (IR) 3.7 (1.8–7.4) 4.0 (1.9–10.4) 2.7 (1.6–5.3) 0.112
Hemoglobin, (g/dl), mean ± SD 10.7±1.6 10.6±1.6 10.8±1.7 0.680
Phosphorus, (mg/dl), mean ± SD 5.5±1.5 5.3±1.5 6.0±1.5 0.085
Albumin, g/dl, median (IR) 3.7 (3.5–3.9) 3.7 (3.5–3.9) 3.8 (3.5–4.1) 0.152
Parathyroid hormone, (ng/L) median (IR) 537.5 (343.7–786.7) 548 (346.7–796.5) 484.5 (309.7–750.0) 0.420
Kt/V, mean ± SD 1.7±.0.2 1.7±0.2 1.6±0.2 0.056
Creatinine, mg/dl, median (IR) 9.1 (6.8–10.4) 9.0 (6.5–10.2) 9.4 (7.4–10.9) 0.180
Charlson comorbidity index, median (IR) 3 (2–5) 4 (2–5) 3 (2–4) 0.171
BMI: body mass index
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Frequency of depressive symptoms in HD population is reported between 0 and 100%
depending on the study and assessment tool [6]. Although it is unknown during the COVID-
19 pandemic in the HD population, depressive symptom frequency was found between 18.7–
35.4% in population-based studies [22–26]. Mazza et al have demonstrated that the risk of
depressive symptoms was increased 22% more if medical problems were positive [27] which
might be translated as depressive symptoms were expected more in HD population.
Mental health studies with the Syrian refugee population in Turkey out of the pandemic
time were found depressive symptom frequency as 36.1%, 37.4%, and 70.5% [28–30]. There is
a sensitivity for the protection of both physical and mental health of refugees or immigrants
during the COVID-19 pandemic [31–34] although no published studies could be found.
Yilmaz et al have shown that Syrian maintenance HD patients were less compliant with
their HD schedules [35]. Their per capita income was lower than Turkish patients, although
their employment rate was higher. The number of Syrian household members was higher than
Turkish patients but hot water accessibility was lower for the Syrian group. Similar BDI scores
might be expected between Turkish and Syrian patients if the conditions were the same for
both groups. However, providing equal physical and financial conditions only at peridialysis
environment seemed to be insufficient for equal score expectation because we found that total
BDI score, somatic-performance subscale score and affective-cognitive subscale score were all
higher in Syrian patients than Turkish ones. As a result, it seems that we need to provide many
other facilities to talk about equality between the two groups. These might be steps to improve
language barrier between adult Syrian patients and Turkish service providers at all facilities
including hospitals and other institutions. This could be with two methods: enabling Syrians
to learn Turkish and maintaining more translation support at every institution or integrating
native Syrian employees to these institutions like hospitals. Language support would help inte-
gration with the Turkish population. Most importantly, they should have been accepted and
behaved like as others in Turkey, not as refugees. Integrating 4 million people into an econom-
ically hard stressed country in the midst of a pandemic is not easy but it seems as a necessity.
To the best of our knowledge, this is the first HD study comparing Turkish patients’ and
Syrian refugees’ depressive symptoms. The main limitation of this study is the absence of con-
trol BDI scores of this cohort out of the pandemic period. Even though it will not change the
Fig 2. Distribution of BDI scores for nationalities. Every circle represents a Turkish, a triangle represents a Syrian
patient. The median BDI score was 12 (7–23) for Turkish patients, 19.5 (12.7–25.2) for Syrian patients (p = 0.03).
https://doi.org/10.1371/journal.pone.0244347.g002
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main result that the Syrian patients have had more depressive symptoms during the COVID-
19 pandemic, we cannot infer how COVID-19 affected the results exactly. Control BDI scoring
was not performed because the number of cases continues to be high enough to ignore the
effects of pandemic even though many precautions were reversed recently. Moreover, the
exact time for the exact reversal of pandemic is not known.
Besides measures taken until now, additional national measures for better integration and
more mental support for Syrian HD patients are needed.
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